Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Jun;17(6):771-2.
doi: 10.1093/neuonc/nov070. Epub 2015 May 10.

Immunotherapy for glioblastoma: are we finally getting closer?

Affiliations
Editorial

Immunotherapy for glioblastoma: are we finally getting closer?

Michael Lim. Neuro Oncol. 2015 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Schuster J, Lai RK, Recht LD, et al. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol. 2015;17(6):854–861. - PMC - PubMed
    1. Weiss SA, Chandra S, Pavlick AC. Update on vaccines for high-risk melanoma. Curr Treat Options Oncol. 2014;15(2):269–280. - PubMed
    1. Jacobs JJ, Snackey C, Geldof AA, et al. Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer. Anticancer Res. 2014;34(6):2689–2700. - PubMed
    1. Waziri A. Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin N Am. 2010;21(1):31–42. - PubMed
    1. Lampson LA. Brain tumor immunotherapy: seeing the brain in the body. Drug Discov Today. 2013;18(7–8):399–406. - PubMed